BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2008
View Archived Issues
BMD increased by percutaneous injection of novel GEM-OS2 in preclinical studies
Read More
Bone formation enhanced with GSK's calcium-sensing receptor antagonist ronacaleret
Read More
New agents for diabetic nephropathy disclosed in recent Kowa patent
Read More
Recent Wyeth patent reports novel bazedoxifene prodrugs
Read More
AEterna completes enrollment in phase III study of LHRH antagonist cetrorelix in BPH
Read More
Boehringer and Evec sign license agreement for fully human therapeutic antibody program
Read More
Athera and Dyax sign collaboration agreement for antibodies in cardiovascular inflammation
Read More
Calabar initiates phase II study of Xalieve in xerostomia
Read More
AEterna initiates second stage of patient recruitment in phase II ovarian cancer trial of AEZS-108
Read More
Novel agents for cardiovascular disorders described in recent patent literature
Read More
deCODE files IND for DG-071 for Alzheimer's disease and other cognitive disorders
Read More
Genentech, Roche and Glycart sign development agreement for monoclonal antibody GA-101
Read More
Genentech reports case of PML in patient who received Raptiva for more than 4 years
Read More
Crucell receives contract from NIAID to advance Ebola and Marburg vaccines
Read More
DSMB recommends continuation of BioMS Medical's MAESTRO-03 trial of dirucotide in MS
Read More
Lilly and Deciphera sign agreement for B-Raf kinase inhibitors for cancer treatments
Read More
Astellas launches Irribow in Japan for diarrhea-predominant IBS
Read More
CombinatoRx reports top-line results from phase IIb Synavive study
Read More
Dendreon presents interim data from phase III Provenge trial
Read More
PDC Biotech reports progress on preclinical program for PDC-31
Read More
Rifaximin achieves significant results in prevention of hepatic encephalopathy
Read More
Unigene initiates phase I study for oral PTH
Read More
Lilly to acquire ImClone Systems
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Vectura Group
Read More
Novel pharmacological chaperones identified as promising agents to treat phenylketonuria
Read More
Adjuvant therapy with catumaxomab safe in phase II gastric cancer study
Read More